MedTrace Logo

Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study

NCT06577857 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2024-09-26

No results posted yet for this study

Summary

A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).

Conditions

Interventions

DEVICE

Inferonasal Minimally Invasive Micro Sclerostomy

The Inferonasal MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the inferonasal quadrant of the eye.

Sponsors & Collaborators

  • Sanoculis Ltd

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-04
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Armenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06577857 on ClinicalTrials.gov